Evidence map›Paper›PMID 39754855›Full record

ArticleSocial science & medicine (1982)2025

Evaluating the psychosocial experiences of participants in HIV cure research before, during, and after analytical treatment interruptions: A longitudinal qualitative study in the United States.

Miranda Hill, Lidia Rodriguez Garcia, Elizabeth Nguyen, Anastasia Korolkova, Lillian Cohn, Antonio Rodriguez, Rebecca Hoh, Steven G Deeks, Michael J Peluso, John A Sauceda and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Social science & medicine (1982), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Trial
  2. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Miranda HillDivision of Prevention Science, Department of Medicine, School of Medicine, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, United States.
Lidia Rodriguez GarciaDivision of Prevention Science, Department of Medicine, School of Medicine, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, United States.
Elizabeth NguyenDivision of Prevention Science, Department of Medicine, School of Medicine, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, United States.
Anastasia KorolkovaDivision of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0507, La Jolla, CA, 92093, United States.
Lillian CohnVaccine & Infection Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, United States.
Antonio RodriguezDivision of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, 1001 Potrero Ave, San Francisco, CA, 94110, United States.
Rebecca HohDivision of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, 1001 Potrero Ave, San Francisco, CA, 94110, United States.
Steven G DeeksDivision of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, 1001 Potrero Ave, San Francisco, CA, 94110, United States.
Michael J PelusoDivision of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, 1001 Potrero Ave, San Francisco, CA, 94110, United States.
John A SaucedaDivision of Prevention Science, Department of Medicine, School of Medicine, University of California, San Francisco, 550 16th Street, San Francisco, CA, 94158, United States.
Karine DubéDivision of Infectious Diseases and Global Public Health, School of Medicine, University of California, San Diego, 9500 Gilman Drive, MC 0507, La Jolla, CA, 92093, United States. Electronic address: kdube@health.ucsd.edu.

Funding

TRAINEESHIPS IN AIDS PREVENTION STUDIEST32MH019105 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carol Suzanne Camlin, Glenn-Milo Santos · 1989 to 2026
$15.3M
Investigating Psychosocial Experiences of HIV Cure Trial Participants Undergoing Extended HIV Treatment Interruptions: Implications for Ethical ConductR01MH126768 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUBE, KARINE, SAUCEDA, JOHN ANDREW · 2021 to 2025
$3.6M
Characterizing the virologic and immunologic signatures of HIV exceptional controlK23AI157875 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PELUSO, MICHAEL JOSEPH · 2021 to 2025
$927k
Unveiling Pathways to Ending HIV Among African American Women: Leveraging Social Networks to Enhance HIV Testing and Treatment Engagement Among MigrantsK01MH134744 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Miranda Hill · 2024 to 2026
$654k
NIAID NIH HHS K23 AI157875NIMH NIH HHS K01 MH134744NIMH NIH HHS R01 MH126768NIMH NIH HHS T32 MH019105
6 · The paper itself

Abstract

The lack of socio-behavioral research on stress and psychosocial experiences among research participants who undergo analytical treatment interruption (ATI) in HIV cure studies underscores a critical gap in cure science. Existing literature acknowledges mixed and potentially adverse mental health impacts of ATIs among trial participants, but empirical insights before, during, and after clinical studies are scarce. We used longitudinal in-depth interviews with 11 participants in HIV cure-related research to explore their experiences with stress, coping, and psychological well-being before, during, and after an ATI. Our framework analyses of participant interviews suggest an evolving interplay between person- and environment-oriented factors that shape psychosocial well-being through multiple pathways. Key emergent themes surrounding stress, coping, and psychological adaptation before the ATI encompass the stress-protective effects of pill (in)significance, curiosity in natural immunological control, and perceived support, and trust with professional help networks comprised of providers and research staff. Themes that promoted positive secondary appraisals of stressors during ATIs involved generativity and meaning-based coping, and the stress-adaptive benefits of support-seeking and actualization. Finally, a theme exposing post-ATI stress revolved around the disappointment that participants noted feeling from needing to restart their HIV medications after the ATI and accepting the permanency of HIV and medications in their lives. Our findings emphasize the importance of building supportive and trusting relationships with research teams, and specify the stress-buffering mechanisms between emotional, informational, and appraisal support on ATI-related stress. Additionally, we outline multiple implications that advocate for the adoption of several precautionary measures in HIV cure research to mitigate psychosocial risks. By documenting the evolution of psychosocial experiences, we offer valuable insights to inform the design of future studies, ensuring their ethicality, acceptability, and inclusivity.

Indexed as

HIV InfectionsResearch SubjectsStress, PsychologicalAdaptation, PsychologicalAdultFemaleHumansInterviews as TopicLongitudinal StudiesMaleMiddle AgedQualitative ResearchUnited StatesAnalytical treatment interruptionsCopingHIV cure researchPeople with HIVPsychosocial experiencesResearch ethicsStress

Identifiers

PMID39754855
PMCPMC11915557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.